Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 24 de abril del 2007
You may also use Quicktime to view the individual presentation:
Bertil Damato, M.D., Hon. Professor of Ophthalmology, University of Liverpool, Ocular Oncology Service, St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool UK
iTunes Manual Instructions:
Jul 23, 2014 - Long-term survival may be increased in medium-risk prostate cancer patients who receive short-term androgen deprivation therapy before and during radiation treatment compared with men who receive radiation alone. In addition, proton beam therapy may be associated with a decreased risk of disease recurrence after 10 years and has minimal side effects after one year, according to research presented at the 51st Annual Meeting of the American Society for Radiation Oncology, held from Nov. 1 to 5 in Chicago.
May 20, 2013
Apr 18, 2012